Chung Eric
AndroUrology Centre, Brisbane, QLD and Sydney, NSW, Australia.
Department of Urology, Princess Alexandra Hospital, University of Queensland, Brisbane, QLD, Australia.
World J Mens Health. 2023 Apr;41(2):396-402. doi: 10.5534/wjmh.210244. Epub 2022 May 20.
To report a case series of 6 patients with penile glans necrosis (PGN) following prostatic artery embolization (PAE) and review the current literature relating to PAE and PGN, including the emerging role of hyperbaric oxygen therapy (HBOT) for PGN.
All patients have failed medical BPH therapy and chose to undergo PAE over other minimally invasive BPH surgery. Patient demographics, preoperative and postoperative validated questionnaires such as the International Prostate Symptom Severity (IPSS) and International Index of Erectile Function (IIEF) scores, treatment-related adverse events (TRAE) and subsequent treatment for PGN were reviewed. All patients were follow-up with a minimum of 12 months post-PAE.
Between January 2018 and June 2020, six males with a mean age of 52.3 years (44-66 y) received PAE for BPH therapy. An immediate postoperative PGN was recognised in 4 out of 6 patients with the mean penile glans pain score of 3 and 4 patients reported altered penile glans sensitivity. Comparing the mean (and median) IPSS and IIEF-5 scores were 16.5 (16) and 21.3 (21) pre-PAE, there was improvements in IPSS and IIEF-5 scores at 12.0 (12) and 18.0 (18) at 12 months review. All patients reported normal penile glans sensitivity and only 1 patient reported an on-going penile glans pain (score 2). Four patients received HBOT while 2 patients elected for conservative care. All patients reported worse erectile function scores despite complete resolution of PGN.
PGN is a rare but serious complication of PAE with ensuing erectile dysfunction. HBOT appears to expedite the recovery process in men with PGN related to PAE with better erection scores compared to conservative measure.
报告6例前列腺动脉栓塞术(PAE)后发生阴茎头坏死(PGN)的病例系列,并回顾当前与PAE和PGN相关的文献,包括高压氧治疗(HBOT)对PGN的新作用。
所有患者药物治疗良性前列腺增生(BPH)均失败,且选择接受PAE而非其他微创BPH手术治疗。回顾了患者的人口统计学资料、术前和术后经过验证的问卷,如国际前列腺症状严重程度(IPSS)和国际勃起功能指数(IIEF)评分、治疗相关不良事件(TRAE)以及PGN的后续治疗情况。所有患者在PAE后至少随访12个月。
2018年1月至2020年6月,6名平均年龄52.3岁(44 - 66岁)的男性接受了PAE治疗BPH。6例患者中有4例术后立即被诊断为PGN,阴茎头平均疼痛评分为3分,4例患者报告阴茎头感觉改变。PAE术前IPSS和IIEF - 5评分的平均值(和中位数)分别为16.5(16)和21.3(21),在术后12个月复查时,IPSS和IIEF - 5评分分别改善至12.0(12)和18.0(18)。所有患者报告阴茎头感觉正常,只有1例患者报告仍有阴茎头疼痛(评分为2分)。4例患者接受了HBOT,2例患者选择了保守治疗。尽管PGN已完全缓解,但所有患者报告勃起功能评分更差。
PGN是PAE罕见但严重的并发症,会导致勃起功能障碍。与保守治疗措施相比,HBOT似乎能加速PAE相关PGN男性的恢复过程,勃起评分更好。